Vivan Therapeutics

22/05/2026

Thrilled to announce Vivan Therapeutics is in the Onstage 2026 Top 100 list (out of >1600 applicants). At Vivan we are generating biological foundation models based on a proprietary dataset to improve cancer treatment outcomes. We are raising growth funding to commercialise TuMatch globally & scale our dataset. Our platform technology, developed in partnership with Mt Sinai Medical Center, has applications across treatment decision support & discovery & development. Led by leaders in oncology and genomics including a 2nd time founder with a recent pharma exit & the Regius Chair of Precision Medicine for the UK.

30/04/2026

We are thrilled to welcome Dr. Marshall Posner as our Chief Medical Officer at Vivan Therapeutics.
Dr. Posner is a world class leader in the field of medical and a renowned clinical investigator in head & neck . He is a highly accomplished clinical researcher with over 300 peer-reviewed publications including top tier journals. It is truly an honour to have him on board!

16/04/2026

We are very pleased to welcome our latest member, Dr Csiki onto our Medical Advisory Board at Vivan! We look forward to working together to bring personalised treatment recommendations to patients globally.

23/03/2026

Dr. Marshall Posner discusses Vivan’s personalised cancer therapeutics service and the outstanding results it has had cancer patients.

Contact us at [email protected] or visit vivantx.com to find out how we can help.

18/03/2026

We are very pleased to welcome Arthur Kennedy to our commercial advisory team at Vivan Therapeutics! Arthur’s expertise in speciality insurance packages will help facilitate and improve accessibility to personalised cancer therapeutics for more cancer patients globally.

18/03/2026

Our personalised cancer treatment recommendation service specialises in and other .
Contact us at [email protected] or visit vivantx.com to find out how we can help support you or your loved one on your treatment journey.

18/03/2026

Our personalised cancer treatment recommendation service specialises in and other .

Contact us at [email protected] or visit vivantx.com to find out how we can help support you or your loved one on your treatment journey.

26/02/2026

Please join our upcoming webinar March 9, 2026 at 6:00 PM GMT to learn about our personalized cancer therapeutics services, specifically focusing on TuMatch, a software for rapid, personalized GI cancer treatment recommendations.
We utilize a comprehensive genomics-based dataset capturing the full mutational landscape of tumors generated through whole animal disease modeling to generate personalized cancer treatment recommendations.
Our original technology platform was developed at and exclusively licensed in partnership with the Icahn School of Medicine at Mount Sinai New York.

Vivan Therapeutics’s Chief Scientific Officer, Dr. Nahuel Villegas will lead the discussion, alongside leading GI Medical Oncologist Dr. Daniel Krell of HCA Healthcare UK, Royal Free London NHS Foundation Trust, moderated by Vivan’s CEO Laura Towart.

We look forward to seeing you there!

19/02/2026

Vivan’s TuMatch software can identify personalized treatment protocols for esophageal cancer.

Book your consultation with our cancer expert, Dr. Villegas at no cost here:
http://bit.ly/4rR55uI

15/02/2026